Search Results - "Ledo Cepero, M"

Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy by Ruiz Guerrero, E, Ledo Cepero, M J, Ojeda Claro, A V, Soto Delgado, M, Álvarez-Ossorio Fernández, J L

“…INTRODUCTIONRenal angiomyolipoma is a frequent manifestation of Tuberous Sclerosis Complex (TSC), for which everolimus therapy has been recently established as…”
Get full text

Initial experience with abiraterone acetate in patients with castration-resistant prostate cancer by Beardo-Villar, P, Ledo-Cepero, M J, Gavira-Moreno, R, Soto-Delgado, M, Soto-Villalba, J, Alvarez-Ossorio, J L, Juárez-Soto, A

“…To describe the results obtained in 25 males with metastatic castration-resistant prostate cancer (MCRPC) treated with abiraterone (AA). A comparative analysis…”
Get more information

Pre-chemotherapy abiraterone acetate. A proposal of a treatment algorithm in castration resistant prostate cancer by Arrabal-Martín, M, Anglada-Curado, F, Cózar-Olmo, J M, Soler-Martínez, J, Moreno-Jiménez, J, Castiñeiras-Fernández, J, Ledo-Cepero, M J, Beardo-Villar, P, Requena-Tapia, M J, Zuluaga-Gómez, A

“…Prostate cancer treatment remains a challenge for the urologist. Medical control in locally advanced or metastatic prostate cancer is usually performed with…”
Get more information

Transumbilical single port surgery with conventional laparoscopic instruments in horseshoe kidney by Pérez-Lanzac, A, Soto-Villalva, J, Ledo-Cepero, M J, Garcia-Baquero, R, Rosety-Rodriguez, J, Madurga-Patuel, B, Alvarez-Ossorio-Fernández, J L

“…Laparoscopic surgery is following a natural course as it decreases surgical aggression on the abdominal wall without undermining the curative and functional…”
Get more information

Laparoscopic radical prostatectomy in recurrent prostate cancer after radiotherapy by Soto Villalba, J, Ledo Cepero, M, Rosety Rodríguez, J, Conde Gilés, Á, García-baquero García de Paredes, R, Pérez-lánzac de Lorca, A, Amores Bermúdez, J, Cañete, J, Álvarez-ossorio Fernández, J

Get full text

Data from the spanish multicentre observational ANAMET study by Gómez Caamaño, A, Morote, J, Ledo Cepero, M, Pesqueira, D, Tabernero, Á, Gómez Veiga, F, Lorente, J, Porras, M, Lobato, J, Ribal, M, Planas, J

Get full text

Is CRPC definition still valid in the new era of antiandrogens for mHSPC treatment? by Ojeda-Claro, A.V., Ledo-Cepero, M.J., Álvarez-Ossorio, J.L.

Get full text

Consensus document on the implications of standardization of BCG supply in the management of patients with non-muscle-invasive bladder cancer by Rodríguez Faba, Ó., Fernández Gómez, J.M., Guerrero-Ramos, F., Álvarez-Maestro, M., Ledo Cepero, M.J., Unda Urzaiz, M., Martínez-Piñeiro, L., Cózar Olmo, J.M., Redorta, J. Palou, Álvarez-Ossorio, J.L.

“…Patients with non-muscle-invasive bladder cancer (NMIBC) in the intermediate and high-risk groups must receive adjuvant treatment with intravesical Bacillus…”
Get full text

Renal angiomyolipoma and tuberous sclerosis complex: long-term safety and efficacy outcomes of Everolimus therapy by Ruiz Guerrero, E., Ledo Cepero, M.J., Ojeda Claro, A., Soto Delgado, M., Álvarez-Ossorio Fernández, J.L.

“…Renal angiomyolipoma is a frequent manifestation of Tuberous Sclerosis Complex (TSC), for which everolimus therapy has been recently established as a novel…”
Get full text

Safety of nivolumab in metastatic renal cell carcinoma patients: A real-life experience in a Spanish urology setting by Amores Bermúdez, J., Osman García, I., Unda Urzáiz, M., Jiménez Marrero, P., Ledo Cepero, M.J., Llarena, R., Flores Martín, J., Abad Vivas-Pérez, J.I., Rodrigo Aliaga, M., Juarez Soto, A.

“…Nivolumab is an immunotherapy agent that has been an approved treatment for previously treated patients with advanced renal cell carcinoma (RCC). Experience in…”
Get full text